Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase 2 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 3Thoracic 1Sarcoma 1Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myeloid, Acute 184Myelodysplastic Syndromes 82Leukemia 39Leukemia, Myelomonocytic, Chronic 36Recurrence 24Myeloproliferative Disorders 15Congenital Abnormalities 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Large B-Cell, Diffuse 13Neoplasms 11Primary Myelofibrosis 9Melanoma 9Blast Crisis 9Thrombocythemia, Essential 7Polycythemia Vera 7Leukemia, Myelomonocytic, Acute 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Monocytic, Acute 7Hodgkin Disease 7Carcinoma, Non-Small-Cell Lung 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Ovarian Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 6Anemia, Refractory, with Excess of Blasts 6Neoplasm Metastasis 5Lymphoma 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Biphenotypic, Acute 5Lymphoma, Non-Hodgkin 4Lung Neoplasms 4

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Decitabine × Clear all
NCT03295552 2022-04-06

DETECT

Shanghai Jiao Tong University School of Medicine

Phase 2 Terminated
12 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT02839694 2018-07-05

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Sarcoma

NCT00715793 2017-10-03

UPCI-07-008

University of Pittsburgh

Phase 1/2 Completed
39 enrolled 12 charts
Dermatologic

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT00925132 2017-07-02

Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat

University of Iowa

Phase 1/2 Terminated
39 enrolled 8 charts
Dermatologic

Melanoma, Neoplasm Metastasis

NCT00019825 2015-04-29

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

National Cancer Institute (NCI)

Phase 1 Completed
GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡